Article
The Anti-Asthmatic Immune Mechanisms of <em>Mt.b </em>ESAT6-Fc Fusion Protein via Intranasal Immunization in Murine Allergic Asthma
2024-11-07
Abstract excerpt
Currently, therapeutic Fc-fusion protein is used for treating disease. ESAT6 (6-kDa early secretory antigenic target), secreted by Mycobacterium tuberculosis, is involved in immune regulation. Administered via intranasal immunization, ESAT6-Fc fusion protein significantly alleviated allergic airway inflammation and mucus hypersecretion, reduced the proportions of Th2 cells, Th17 cells and eosinophils with no obser...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1733f0c0-ab4e-5683-87e5-7669b58da9ca
- DOI
- 10.20944/preprints202411.0404.v1
